Acute Intermittent Porphyria

Search Trials
Evidence-based Assessment of Medication Sensitivity in Acute Hepatic Porphyria
Status:
Completed
Last Changed:
Oct 16, 2019
First Changed:
Apr 8, 2019
Disease(s):
Porphyrias
Intervention(s):
Web-based Survey
Expanded Access Protocol of Givosiran for Patients With Acute Hepatic Porphyria
Status:
Approved for marketing
Last Changed:
Jan 13, 2022
First Changed:
Aug 14, 2019
Disease(s):
Acute Hepatic Porphyria
Intervention(s):
Givosiran
A Study to Evaluate the Efficacy and Safety of Maralixibat in Subjects With Progressive Familial Intrahepatic Cholestasis (MARCH-PFIC)
Status:
Recruiting
Last Changed:
Sep 14, 2021
First Changed:
Apr 5, 2019
Disease(s):
Progressive Familial Intrahepatic Cholestasis (PFIC)
Intervention(s):
MaralixibatPlacebo
A Placebo-controlled Study of Maralixibat (SHP625) in Pediatric Subjects With Progressive Familial Intrahepatic Cholestasis (PFIC)
Status:
Withdrawn
Last Changed:
Mar 18, 2019
First Changed:
Nov 27, 2017
Disease(s):
Progressive Familial Intrahepatic Cholestasis (PFIC)
Intervention(s):
MaralixibatPlacebo
Assessment of Intra-subject Variability in the Bioavailability of Chlorpromazine Hydrochloride
Status:
Completed
Last Changed:
Nov 14, 2017
First Changed:
Oct 24, 2016
Disease(s):
Anti-Psychotic
Intervention(s):
Chlorpromazine Hydrochloride

Connect. Empower. Inspire.